Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   FIV Gag: Virus assembly and host-cell interactions
  2. Luttge, B. G.; Freed, E. O.
  3. Veterinary Immunology and Immunopathology. 2010, Mar; 134(1-2): 3-13.
  1. 2.   A macaque model of HIV-1 infection
  2. Hatziioannou, T.; Ambrose, Z.; Chung, N.; Piatak, M.; Yuan, F.; Trubey, C. M.; Coalter, V.; Kiser, R.; Schneider, D.; Smedley, J.; Pung, R.; Gathuka, M.; Estes, J. D.; Veazey, R. S.; KewalRamani, V. N.; Lifson, J. D.; Bieniasz, P. D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(11): 4425-4429 DI 10.1073/pnas.
  1. 3.   Mutational Analysis and Allosteric Effects in the HIV-1 Capsid Protein Carboxyl-Terminal Dimerization Domain
  2. Yu, X.; Wang, Q. M.; Yang, J. C.; Buch, I.; Tsai, C. J.; Ma, B. Y.; Cheng, S.; Nussinov, R.; Zheng, J.
  3. Biomacromolecules. 2009 10(2): 390-399.
  1. 4.   Cellular proteins detected in HIV-1
  2. Ott, D. E.
  3. Reviews in Medical Virology. 2008 18(3): 159-175.
  1. 5.   The cell biology of HIV-I and other retroviruses
  2. Freed, E. O.; Moul, A. J.
  3. Retrovirology. 2006, Nov; 3
  1. 6.   Antiretroviral potential of human tripartite motif-5 and related proteins
  2. Zhang, F. W.; Hatziioannou, T.; Perez-Caballero, D.; Derse, D.; Bieniasz, P. D.
  3. Virology. 2006, Sep; 353(2): 396-409.
  1. 7.   The B30.2(SPRY) domain of the retroviral restriction factor TRIM5 alpha exhibits line age-specific length and sequence variation in primates
  2. Song, B. W.; Gold, B.; O'HUigin, C.; Javanbakht, H.; Li, X.; Stremlau, M.; Winkler, C.; Dean, M.; Sodroski, J.
  3. Journal of Virology. 2005, MAY; 79(10): 6111-6121.
  1. 8.   Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1
  2. Kino, T.; Pavlakis, G. N.
  3. DNA and Cell Biology. 2004 23(4): 193-205.
  1. 9.   Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance
  2. Yung, E.; Sorin, M.; Wang, E. J.; Perumal, S.; Ott, D.; Kalpana, G. V.
  3. Journal of Virology. 2004 78(5): 2222-2231.
  1. 10.   Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated
  2. Banks, W. A.; Robinson, S. M.; Wolf, K. M.; Bess, J. W.; Arthur, L. O.
  3. Neuroscience. 2004 128(1): 143-153.
  1. 11.   HIV-1 and the host cell: an intimate association
  2. Freed, E. O.
  3. Trends in Microbiology. 2004 12(4): 170-177.
  1. 12.   Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis
  2. Tozser, J.; Shulenin, S.; Kadas, J.; Boross, M.; Bagossi, M.; Copeland, T. D.; Nair, B. C.; Sarngadharan, M. G.; Oroszlan, S.
  3. Virology. 2003 310(1): 16-23.
  1. 13.   Proteolytic events of HIV-1 replication as targets for therapeutic intervention
  2. Tozser, J.; Oroszlan, S.
  3. Current Pharmaceutical Design. 2003 9(22): 1803-1815.
  1. 14.   Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors
  2. Gatanaga, H.; Suzuki, Y.; Tsang, H.; Yoshimura, K.; Kavlick, M. F.; Nagashima, K.; Gorelick, R. J.; Mardy, S.; Tang, C.; Summers, M. F.; Mitsuya, H.
  3. Journal of Biological Chemistry. 2002 277(8): 5952-5961.
  1. 15.   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
  2. Chertova, E.; Bess, J. W.; Crise, B. J.; Sowder, R. C.; Schaden, T. M.; Hilburn, J. M.; Hoxie, J. A.; Benveniste, R. E.; Lifson, J. D.; Henderson, L. E.; Arthur, L. O.
  3. Journal of Virology. 2002 76(11): 5315-5325.
  1. 16.   Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication
  2. Peng, B.; Voltan, R.; Lim, L.; Edghill-Smith, Y.; Phogat, S.; Dimitrov, D. S.; Arora, K.; Leno, M.; Than, S.; Woodward, R.; Markham, P. D.; Cranage, M.; Robert-Guroff, M.
  3. Journal of Virology. 2002 76(12): 6016-6026.
  1. 17.   Potential roles of cellular proteins in HIV-1
  2. Ott, D. E.
  3. Reviews in Medical Virology. 2002 12(6): 359-374.
  1. 18.   Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells
  2. Tang, S. X.; Murakami, T.; Agresta, B. E.; Campbell, S.; Freed, E. O.; Levin, J. G.
  3. Journal of Virology. 2001 75(19): 9357-9366.
  1. 19.   Actin-binding cellular proteins inside human immunodeficiency virus type 1
  2. Ott, D. E.; Coren, L. V.; Johnson, D. G.; Kane, B. P.; Sowder, R. C.; Kim, Y. D.; Fisher, R. J.; Zhou, X. Z.; Lu, K. P.; Henderson, L. E.
  3. Virology. 2000 266(1): 42-51.
  1. 20.   Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1
  2. Briggs, C. J.; Ott, D. E.; Coren, L. V.; Oroszlan, S.; Tozser, J.
  3. Archives of Virology. 1999 144(11): 2151-2160.
  1. 21.   Microvesicles Are a Source of Contaminating Cellular Proteins Found in Purified Hiv-1 Preparations
  2. Bess, J. W.; Gorelick, R. J.; Bosche, W. J.; Henderson, L. E.; Arthur, L. O.
  3. Virology. 1997 230(1): 134-144.
  1. 22.   Cellular Proteins in Hiv Virions
  2. Ott, D. E.
  3. Reviews in Medical Virology. 1997 7(3): 167-180.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel